Cargando…

The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients

PURPOSE: When only the TNM classification is used to predict survival in gastric cancer (GC) patients, the impact of the degree of lymphadenectomy on the prognosis is neglected. This study aimed to establish a more effective nomogram based on the log odds of negative lymph nodes/T stage ratio (LONT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jiebin, Pang, Yueshan, Li, Xun, Wu, Xiaoting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236481/
https://www.ncbi.nlm.nih.gov/pubmed/34003367
http://dx.doi.org/10.1007/s00432-021-03654-y
_version_ 1783714548280197120
author Xie, Jiebin
Pang, Yueshan
Li, Xun
Wu, Xiaoting
author_facet Xie, Jiebin
Pang, Yueshan
Li, Xun
Wu, Xiaoting
author_sort Xie, Jiebin
collection PubMed
description PURPOSE: When only the TNM classification is used to predict survival in gastric cancer (GC) patients, the impact of the degree of lymphadenectomy on the prognosis is neglected. This study aimed to establish a more effective nomogram based on the log odds of negative lymph nodes/T stage ratio (LONT) to predict survival in surgically treated GC patients. METHODS: The data of resected GC patients were extracted from the Surveillance, Epidemiology, and End Results Program (SEER) database. Univariate and multivariate Cox regression analyses were used to identify the significant prognostic factors. The prognostic performance was assessed using a calibration plot, concordance index (C-index), and area under the (time-dependent receiver operating characteristic) curve (AUC) to compare the predicted survival probability based on the nomogram score groups. RESULTS: The results showed LONT as an independent prognostic factor for cancer-specific survival (CSS) and overall survival (OS), independent of clinicopathological factors. After removing potential redundancy, only LONT, T stage, N stage, location and age were used in the final nomogram model. The model had a higher C-index (0.736 ± 0.012) and AUC (0.798) than the TNM staging system (0.685 ± 0.012 and 0.744). The nomogram score could predict a significant survival difference between any two adjacent groups in terms of CSS and OS. CONCLUSION: High LONT is associated with improved survival of gastric cancer patients, independent of other clinicopathological factors. The prognostic nomogram model based on LONT could effectively predict CSS and OS for resectable GC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-021-03654-y.
format Online
Article
Text
id pubmed-8236481
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82364812021-07-09 The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients Xie, Jiebin Pang, Yueshan Li, Xun Wu, Xiaoting J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: When only the TNM classification is used to predict survival in gastric cancer (GC) patients, the impact of the degree of lymphadenectomy on the prognosis is neglected. This study aimed to establish a more effective nomogram based on the log odds of negative lymph nodes/T stage ratio (LONT) to predict survival in surgically treated GC patients. METHODS: The data of resected GC patients were extracted from the Surveillance, Epidemiology, and End Results Program (SEER) database. Univariate and multivariate Cox regression analyses were used to identify the significant prognostic factors. The prognostic performance was assessed using a calibration plot, concordance index (C-index), and area under the (time-dependent receiver operating characteristic) curve (AUC) to compare the predicted survival probability based on the nomogram score groups. RESULTS: The results showed LONT as an independent prognostic factor for cancer-specific survival (CSS) and overall survival (OS), independent of clinicopathological factors. After removing potential redundancy, only LONT, T stage, N stage, location and age were used in the final nomogram model. The model had a higher C-index (0.736 ± 0.012) and AUC (0.798) than the TNM staging system (0.685 ± 0.012 and 0.744). The nomogram score could predict a significant survival difference between any two adjacent groups in terms of CSS and OS. CONCLUSION: High LONT is associated with improved survival of gastric cancer patients, independent of other clinicopathological factors. The prognostic nomogram model based on LONT could effectively predict CSS and OS for resectable GC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-021-03654-y. Springer Berlin Heidelberg 2021-05-18 2021 /pmc/articles/PMC8236481/ /pubmed/34003367 http://dx.doi.org/10.1007/s00432-021-03654-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article – Cancer Research
Xie, Jiebin
Pang, Yueshan
Li, Xun
Wu, Xiaoting
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
title The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
title_full The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
title_fullStr The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
title_full_unstemmed The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
title_short The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
title_sort log odds of negative lymph nodes/t stage: a new prognostic and predictive tool for resected gastric cancer patients
topic Original Article – Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236481/
https://www.ncbi.nlm.nih.gov/pubmed/34003367
http://dx.doi.org/10.1007/s00432-021-03654-y
work_keys_str_mv AT xiejiebin thelogoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT pangyueshan thelogoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT lixun thelogoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT wuxiaoting thelogoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT xiejiebin logoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT pangyueshan logoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT lixun logoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients
AT wuxiaoting logoddsofnegativelymphnodeststageanewprognosticandpredictivetoolforresectedgastriccancerpatients